Calendar Allergy Therapeutics plc

Equities

AGY

GB00B02LCQ05

Delayed London S.E. 04:42:25 2024-04-24 am EDT 5-day change 1st Jan Change
2.88 GBX +2.86% Intraday chart for Allergy Therapeutics plc +1.05% +15.20%

Chart calendar Allergy Therapeutics plc

6152bf5f2b10.KxJRjBIHbetLa0LwpC0d0HbvtsJnKwdxEfnldh4Jmkw.R1U7_nNYAL0DWyXClEglikGh45EDSmZCTpa1OSZGqQF9KhLBcU8Hm3s_NQ~46cf06c45e18f85947fcb8eda26731cd

Upcoming events on Allergy Therapeutics plc

2024-09-24 Q4 2024 Earnings Release (Projected)
2025-03-04 Q2 2025 Earnings Release (Projected)
2025-09-23 Q4 2025 Earnings Release (Projected)
2026-03-10 Q2 2026 Earnings Release (Projected)

Past events on Allergy Therapeutics plc

2024-03-27 03:00 am Q2 2024 Earnings Release
2024-03-08 06:00 am Annual General Meeting
2024-02-14 02:00 am Q2 2024 Sales and Revenue Release - Trading Update
2023-09-27 Rights Issue: 6 new shares @ 0.01 GBP for 1 existing share
2023-09-27 02:00 am Q4 2023 Earnings Release
2023-08-10 02:00 am Q4 2023 Sales and Revenue Release - Trading Update
2023-07-31 07:00 am Shareholders Meeting
2023-06-19 02:01 am Q2 2023 Earnings Release
2023-06-10 08:30 am European Academy of Allergy and Clinical Immunology Congress
2023-04-27 07:00 am Shareholders Meeting
2023-02-07 04:30 am Annual General Meeting
2023-01-20 02:00 am Interim 2023 Sales and Revenue Release - Trading Update
2022-10-17 06:00 am Shareholders Meeting
2022-10-03 05:00 am FY 2022 Earnings Call - Second Call
2022-09-29 07:00 am FY 2022 Earnings Call
2022-09-29 02:00 am FY 2022 Earnings Release
2022-09-12 09:00 am H.C. Wainwright Global Investment Conference - Fireside Chat
2022-07-15 02:00 am FY 2022 Sales and Revenue Release - Trading Update
2022-05-24 07:00 am H.C. Wainwright Global Investment Conference
2022-03-10 05:30 am Investor Meeting

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million GBP
Released
Forecast
Spread
73,7
73,9
-0.25%
78,2
78,2
0%
84,3
84,3
0.03%
72,8
74,2
-1.89%
61,0
64,9
-6.08%
EBITDA
Million GBP
Released
Forecast
Spread
6,48
2,02
220.84%
12,2
7,60
60.78%
8,16
5,17
57.88%
-8,08
-6,51
-24.13%
-31,9
-19,7
-61.94%
EBIT
Million GBP
Released
Forecast
Spread
4,39
-3,49
225.82%
8,31
3,90
112.87%
4,03
1,59
153.16%
-12,2
-10,6
-15.45%
-36,1
-25,7
-40.58%
Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
4,29
2,70
59%
8,07
5,93
36.22%
3,66
1,25
192.02%
-12,7
-11,1
-14.16%
-49,8
-26,1
-90.92%
Net income
Million GBP
Released
Forecast
Spread
3,47
2,00
73.35%
7,06
4,55
55.12%
2,89
0,67
332.47%
-13,8
-12,0
-15.02%
-51,0
-26,9
-89.69%
EPS
GBP
Released
Forecast
Spread
0,01
0,00
108%
0,01
0,01
40%
0,00
0,00
330%
-0,02
-0,02
-16.43%
-0,08
-0,02
-280.5%
Announcement Date25/09/1923/09/2023/09/2129/09/2227/09/23

Quarterly results

Fiscal PeriodJune 2020 S1 2022 S1 2022 S2 2023 S1 2023 S2
Net sales
Million GBP
Released
Forecast
Spread
50,5
51,8
-2.56%



24,1
24,1
-0.12%
39,9
39,9
0%
21,1
25,0
-15.8%
EBITDA
Million GBP
Released
Forecast
Spread






-17,9
-10,9
-64.18%
-5,84
-5,00
-16.74%
-26,1
-14,8
-76.12%
EBIT
Million GBP
Released
Forecast
Spread






-19,7
-13,3
-47.83%
-7,96
-8,00
0.54%
-28,2
-17,8
-58.27%
Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread






-19,9
-13,5
-47.58%
-8,20
-8,20
0%
-41,6
-18,0
-131.27%
Net income
Million GBP
Released
Forecast
Spread



6,67


-20,4
-13,5
-51.46%
-8,51
-8,90
4.43%
-42,5
-18,0
-136.22%
EPS
GBP
Released
Forecast
Spread
0,02
0,02
-1.3%
0,01


-0,03
-0,02
-55.5%
-0,01
-0,01
-29%
-0,06
0,00
-
Announcement Date04/03/2003/03/2229/09/2219/06/2327/09/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AGY Stock
  4. Calendar Allergy Therapeutics plc